Background: Berlin is internationally known for its nightlife. In a nation-wide and Europe-wide comparison, the use of legal and illegal substances is comparatively higher in Berlin than in other similar cities. However, few data exist about the drug use in the party scene. Objective: This study aims to assess the sociodemographic characteristics of Berlin’s party scene and its patterns of substance use as well as expectations towards prevention in order to derive appropriate preventive measures. Methods: Using questionnaires, both online (n = 674) and in the field (n = 203), a total of 877 people of the Berlin party scene were interviewed. The questionnaires ascertained the demographic information of the participants and patterns of substance use in the scene. It also collected the demand for consulting services and personal assessments on the usefulness of prospective and existing prevention programs and offers. Results: The study participants were 29 years old (SD 7.5); 43% were female. Alcohol is the most common substance in the party scene, followed by cannabis, MDMA/Ecstasy, amphetamine, cocaine, and ketamine. In this particular cohort, methamphetamine and “legal highs” did not play a major role. The most demanded preventive measure was more education about drugs and the so called drug-checking. Conclusions: Prevention in this area is both needed and requested, and an expansion of the existing programs (e.g., by so far politically controversial drug-checking) should be considered.

Keywords:
Substance use, Prevention, Party drugs, Nightlife, Berlin, Drugs, Drug checking, Clubs, Party scene
1.
Chinet L, Stéphan P, Zobel F, Halfon O. Party drug use in techno nights: a field survey among French-speaking Swiss attendees.
Pharmacol Biochem Behav
. 2007 Feb;86(2):284–9.
2.
Hannemann TV, Kraus L, Piontek D. Consumption Patterns of Nightlife Attendees in Munich: A Latent-Class Analysis.
Subst Use Misuse
. 2017 Sep;52(11):1511–21.
3.
Tossmann P, Boldt S, Tensil MD. The use of drugs within the techno party scene in European metropolitan cities.
Eur Addict Res
. 2001 Mar;7(1):2–23.
4.
Soellner R. Club drug use in Germany.
Subst Use Misuse
. 2005;40(9–10):1279–93.
5.
Kraus L, Pabst A, Gomes de Matos E, Piontek D. 2012 Epidemiological Survey of Substance Abuse in the Adolescent and Adult Population of Berlin. München, IFT Institut für Therapieforschung, 2014.
6.
Coldwell W. Nighlife reports: clubbing in Berlin. The Guardian, 2016.
7.
Sullivan P.
Berlin nightlife
. The Telegraph, 2017.
8.
Resident Advisor. Guide to Berlin: Resident Advisor, 2017. Available from: https://www.residentadvisor.net/guide/de/berlin.
9.
Maier LFJ, Barrat M, Winstock A. Global Drug Survey 2017. Berlin Nights Conference, 2017.
10.
Betzler F, Heinz A, Köhler S. [Synthetic Drugs - An Overview of Important and Newly Emerging Substances].
Fortschr Neurol Psychiatr
. 2016 Nov;84(11):690–8.
11.
Verbraucherschutz BdJuf. NpSG - Neue-psychoaktive-Stoffe-Gesetz vom 21. November 2016 (BGBl. I S. 2615), das zuletzt durch Artikel 6 Absatz 8 des Gesetzes vom 13. April 2017 (BGBl. I S. 872) geändert worden ist. In: Verbraucherschutz BdJuf.
12.
Leitlinien für die Suchtprävention im Land Berlin, 2006.
13.
Betzler F, Ernst F, Helbig J, Viohl L, Roediger L. Substanzkonsum und Präventionsangebote Berlin - Eine Untersuchung zur aktuellen Situation bezüglich des Substanzkonsums und den Erwartungen an Präventionsangebote in der Berliner Partyszene, 2018.
14.
EMCDDA: Perception of Risks Associated with Drug Use. Lisbon, European Monitoring Centre for Drugs and Drug Addiction, 2004.
15.
Brown RL, Rounds LA. Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice.
Wis Med J
. 1995;94(3):135–40.
16.
Hauptstadtportal: Clubguide, 2017. Available from: https://www.berlin.de/clubs-und-party/clubguide/.
17.
Boys A, Marsden J, Strang J. Understanding reasons for drug use amongst young people: a functional perspective.
Health Educ Res
. 2001 Aug;16(4):457–69.
18.
EMCDDA. Wastewater analysis and drugs – a European multi-city study. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2018.
19.
Winstock AR, Wolff K, Ramsey J. Ecstasy pill testing: harm minimization gone too far?
Addiction
. 2001 Aug;96(8):1139–48.
20.
Benschop A, Rabes M, Korf DJ.
Pill Testing-Ecstasy & Prävention. Eine wissenschaftliche Evaluationsstudie in drei Europäischen Städten
. Amsterdam: Rosenberg; 2003.
21.
Hungerbuehler I, Buecheli A, Schaub M. Drug Checking: A prevention measure for a heterogeneous group with high consumption frequency and polydrug use - evaluation of zurich’s drug checking services.
Harm Reduct J
. 2011 Jun;8(1):16.
22.
Brunt TM, Nagy C, Bücheli A, Martins D, Ugarte M, Beduwe C, et al. Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project.
Drug Test Anal
. 2017 Feb;9(2):188–98.
23.
Brunt TM, Niesink RJ. The Drug Information and Monitoring System (DIMS) in the Netherlands: implementation, results, and international comparison.
Drug Test Anal
. 2011 Sep;3(9):621–34.
24.
Jacobi F, Wittchen HU, Holting C, Höfler M, Pfister H, Müller N, et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS).
Psychol Med
. 2004 May;34(4):597–611.
25.
Statista: Bevölkerungsanteil mit psychischen Erkrankungen in Deutschland nach Geschlecht und Altersgruppe im Jahr 2011. Statista - Das Statistikportal, 2011.
26.
Pabst A, Kraus L, Gomes de Matos E, Piontek D. Substanzkonsum und substanzbezogene Störungen in Deutschland im Jahr 2012.
Sucht
. 2013;59(6):321–31.
27.
Dalia Research.
6% of Europeans identify as Lesbian, Gay, Bisexual, or Transgender
. LGBT, 2016.
28.
Lea T, Reynolds R, de Wit J. Alcohol and club drug use among same-sex attracted young people: associations with frequenting the lesbian and gay scene and other bars and nightclubs.
Subst Use Misuse
. 2013 Jan;48(1–2):129–36.
29.
Gomes de Matos E, Atzendorf J, Kraus L, Piontek D. Substanzkonsum in der Allgemeinbevölkerung in Deutschland.
Sucht
. 2016;62:271–81.
30.
Kelly BC, Parsons JT, Wells BE. Prevalence and predictors of club drug use among club-going young adults in New York city.
J Urban Health
. 2006 Sep;83(5):884–95.
31.
Boyd CJ, McCabe SE, d’Arcy H. Ecstasy use among college undergraduates: gender, race and sexual identity.
J Subst Abuse Treat
. 2003 Apr;24(3):209–15.
32.
Viohl L, Ernst F, Gabrysch J, Petzold MB, Köhler S, Ströhle A, et al. ‘Higher education’ - substance use among Berlin college students.
Eur J Neurosci
. 2019, Epub ahead of print.
34.
Nordfjærn T, Bretteville-Jensen AL, Edland-Gryt M, Gripenberg J. Risky substance use among young adults in the nightlife arena: an underused setting for risk-reducing interventions?
Scand J Public Health
. 2016 Nov;44(7):638–45.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.